Tumor cells were positive for periodic acid-Schiff (PAS) reaction and immunoreactive for CD99 (Figure 4B), NKX2.2 and the neuroendocrine markers CD56 and synaptophysin. The gene discussed is NKX2-2; the disease is neoplasm.